T. Rowe Price

T. Rowe Price is a publicly owned investment management firm founded in 1937 and headquartered in Baltimore, Maryland. The company serves a diverse clientele that includes individuals, institutional investors, retirement plans, and financial intermediaries. T. Rowe Price offers a wide array of investment strategies encompassing equity, fixed income, and private equity, with a particular focus on funding technology startups. The firm employs a combination of fundamental and quantitative analysis to guide its investment decisions, utilizing both in-house and external research. Additionally, T. Rowe Price is committed to socially responsible investing, prioritizing environmental, social, and governance factors. With a global presence, the firm operates offices in numerous locations worldwide, enhancing its ability to navigate various markets and deliver reliable investment solutions.

Zunaira Ashraf

Associate

Oliver Bell

Portfolio Manager

Tyler Cunningham

Associate

Timothy Scott Dignan

VP, Controller and Treasurer

Henry Ellenbogen

Portfolio Manager

John Raymond Gilner

Managing Counsel and Chief Compliance Officer

Edward F. Giltenan

Head of Global Public Relations & VP

Vishnu Vardhan Gopal

Vice President

Robert Higginbotham

Head of Global Investment Services

Justin Ho

Associate

Philip Jay Kligman

Assistant VP

Priscilla Luong

Associate

Eric C. Moffett

VP

Jared Murphy

Investment Analyst

Jason Nogueira

Portfolio Manager of Global Consumer Fund (PGLOX)

Sebastien Page

Head of Global Multi-Asset

Dante Pearson

Investment Analyst

Sharps C.F.A., CPA, CFA, CPA, Robert W.

Co-Head of Global Equity and Group Chief Investment Officer

William Stromberg

President and Chief Executive Officer

Eric L. Veiel

Head of U.S. Equity

Teresa Whitaker

Investor Relations Manager

Past deals in British Columbia

Clio

Series E in 2021
Themis Solutions Inc. develops legal practice management and client intake software solutions for law firms. The company’s platforms are used for billing, case management, contact management, document management, calendaring, online payments, and time and expense tracking. The company was founded in 2007 and is based in Burnaby, Canada with additional offices in Toronto, Calgary, Canada; Santa Monica, California; and Dublin, Ireland.

Kardium

Private Equity Round in 2021
Kardium Inc. is a medical solutions company based in Burnaby, Canada, specializing in the diagnosis and treatment of atrial fibrillation (AF). Founded in 2007, the company has developed the Globe Mapping and Ablation System, which streamlines AF treatment by integrating single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation into a single catheter. This advanced system aids medical practitioners in diagnosing and treating cardiovascular diseases by providing detailed electrophysiological mapping and the ability to ablate cardiac tissue using radio-frequency energy. Kardium's team comprises experts in medicine, engineering, and research, ensuring a robust foundation for innovation in medical device technology.

Kardium

Private Equity Round in 2019
Kardium Inc. is a medical solutions company based in Burnaby, Canada, specializing in the diagnosis and treatment of atrial fibrillation (AF). Founded in 2007, the company has developed the Globe Mapping and Ablation System, which streamlines AF treatment by integrating single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation into a single catheter. This advanced system aids medical practitioners in diagnosing and treating cardiovascular diseases by providing detailed electrophysiological mapping and the ability to ablate cardiac tissue using radio-frequency energy. Kardium's team comprises experts in medicine, engineering, and research, ensuring a robust foundation for innovation in medical device technology.